Ca - A Cancer Journal for Clinicians 1991: Vol 41 Index

13 Pages·1991·1.6 MB·English

Subject Index, 1991
Summary table, 273
Year of acquisition, 267
Vol. 41, Nos. 1-6
Aminopterin, 267
Amsacrine, 267, 275
A
Androgens
Acquired immune deficiency syndrome Breast cancer, metastatic, treatment of,
(AIDS), randomization in clinical trials, ethics 246
of, 183-184 (Opinion) Summary table, 273
Year of acquisition, 267
Adrenal cortex cancer, chemotherapeutic
and biologic agents, 266 Announcements
American Cancer Society Clinical Awards,
Adrenalectomy, bilateral, breast cancer, 179
metastatic, treatment of, 247 American Cancer Society Grants and
Awards for Clinical Research, 372
Alcohol consumption American Cancer Society Great American
Breast cancer and, 153-154 Smokeout, 309
Cancer risk and, 336 American Cancer Society National
Conference on Cancer Nursing, 96
American Association of Central Cancer American Cancer Society National
Registration (AACCR), 7 Conference on Gynecologic Cancers,
356
American Cancer Society American Cancer Society National
Clinical Awards, 179 Conference on Prostate Cancer, 300,
365
Grants and Awards for Clinical Research,
372 American Cancer Society Second National
Conference on Cancer Nursing
Great American Smokeout, 309
Guidelines for Cancer-Related Checkup: Research, 320, 338
An Update, 279-282 American Cancer Society Textbook of
Guidelines on Diet, Nutrition, and Cancer, Clinical Oncology, 200
334-338 American Cancer Society World
The National Cancer Data Base, 5-6 Conference on Tobacco or Health,
(Editorial) “Building a Tobacco-Free World,” 241
National Conference on Cancer Nursing,
96 Anti-estrogens, 273
National Conference on Cancer Nursing
Research, Second, 320, 338 Artificial sweeteners, cancer risk and,
National Conference on Gynecologic 336
Cancers, 356
Ascites, malignant, malignant effusions,
National Conference on Prostate Cancer,
300, 365 175-177
Neuroblastoma screening workshop,
consensus statement from, do children Asparaginase, 267, 275
benefit from mass screening for
neuroblastoma?, 227-230 AZT (zidovudine), randomization, ethics of,
Nutrition and cancer, 325-327 (Guest 183-184 (Opinion)
editorial), 334-338
Stop-smoking materials available from,
136
B
Textbook of Clinical Oncology, 200
World Conference on Tobacco or Health,
“Building a Tobacco-Free World,” 241 Basic Science Overview, The Process of
Metastasis, 301-305
American Joint Committee on Cancer
(AJCC), 17 Benign nevi, juvenile melanoma
differentiated from, 45—46 (Classic)
Aminoglutethamide
Breast cancer, metastatic, treatment of, Bilateral adrenalectomy, breast cancer,
246 metastatic, treatment of, 247
VOL. 41,NO.6 NOVEMBER/DECEMBER 1991
Bilateral oophorectomy, breast cancer, Sexuality, body image, intimate
metastatic, treatment of, 245 relationships and, 112-120
Staging and, 9, 121-125
Biliary tract cancer Surgical management of, 71-84, 370-371
Incidence, 28 (Letter)
Mortality, 29 Survival rates, 11, 13, 15, 20, 36, 77, 79,
; 81
Bleomycin, 267, 272 Trseaaittmhen t aaauantaet istics, 10
Breast self-examination, early detection,
Blood, malignant effusions, 166-179 281
Body image, breast cancer’s impact on, and Bronchial cancer
sexuality and intimate relationships, 112-120 Stage at diagnosis, 8
Survival rates, 11, 12, 15, 36
Treatment type statistics, 10
Bone cancer
Mortality, 23, 29 Busulfan, 267, 270
Stage at diagnosis, 8
Survival rates, 11, 13, 15, 35
Treatment type statistics, 10
Brain cancer i ee a
Breast cancer, metastatic, treatment of, Cancer staging (See Staging)
243
Incidence, 28 Carboplatin, 264, 267, 276
Mortality, 23, 29
Survival rates, 35, 36 Cardiac tamponade, pericardial effusions,
malignant effusions, 174
Breast cancer
Biological perspective of, contributions of Carmustine, 267, 275
the National Surgical Adjuvant Breast
and Bowel Project, clinical trials, Cell therapy (See Fresh cell therapy)
97-111
“Change and Challenge,” 69-70 Central nervous system cancer
(Editorial) Incidence, 28
Chemotherapeutic and biologic agents, Mortality, 23, 29
266 Stage at diagnosis, 9
Chemotherapy in management of, Survival rates, 11, 14, 15, 35, 36
231-241 Treatment type statistics, 10
Conservative surgery and radiation
therapy (CS + RT) in management of, Cervical cancer
71-84 Chemotherapeutic and biologic agents,
Early detection, 279-280 266
Epidemiology of, 146-165 Early detection, 280
Incidence, 19, 21, 28, 30, 149 Incidence, 21, 28
Male, 253, 339-354 Mortality, 29
Epidemiology, 339-342 Stage at diagnosis, 9
Histology and staging, 343-345 Survival rates, 11, 13, 15, 20, 36
Local treatment, 345 Treatment type statistics, 10
Presentation and diagnosis, 342-343
Recurrence and dissemination Checkups, early cancer
management, 348-351 detection/prevention, American Cancer
Systemic adjuvant therapy, 345, 348 Society Guidelines for Cancer-Related
Mammography, 369-370 (Letter) Checkup: An Update, 279-282
Metastatic, treatment of, 242-256. See
also Metastatic disease: breast cancer Chemotherapy (See a/so Pharmacology)
Mortality, 19, 23, 26, 29, 31, 32, 77 Agent mechanism of action, 268
Pathologist’s role in management of, Breast cancer, biological perspective of,
283-299 contributions of the National Surgical
Radiation therapy in management of, Adjuvant Breast and Bowel Project,
85-96 Clinical trials, 97-111
CA-A CANCER JOURNAL FOR CLINICIANS
Breast cancer, impact of, on sexuality, Adjuvant Breast and Bowel Project,
body image, and intimate relationships, 97-111
116-117 Breast cancer, primary, chemotherapy in
Breast cancer, male, 13, 339-354 management of, 231-241
Breast cancer, metastatic, treatment of, Randomization, ethics of, 180-186
247-251 (Opinion)
Breast cancer, primary, role in
management of, 231-241 Coffee, cancer risk and, 336
Cancer chemotherapeutic and biologic
agents, 264-278 Colon cancer
Evolution of chemotherapy, 261-263 Chemotherapeutic and biologic agents,
(Guest Editorial) 266
Incidence, 19, 21, 28, 30, 147
Childhood cancers Mortality, 19, 23, 26, 27, 29, 31, 32
Care of the child dying of cancer, 52-60 Stage at diagnosis, 8
Chemotherapeutic and biologic agents, Survival rates, 11, 12, 15, 20, 36
265 Treatment type statistics, 10
Melanomas of childhood, 37—51 (Classic)
Neuroblastoma screening workshop, Compound nevus, 205
American Cancer Society, consensus
statement from, do children benefit from
Congenital melanocytic nevi, 208-209
mass screening for neuroblastoma?,
227-230
Survival rates, 35 Connective tissue cancer, mortality, 23, 29
Chliorambucil, 267, 270 Cooking temperature, cancer risk and,
337-338
2-Chlorodeoxyadenosine, 267
Corpus uteri cancer
Cholesterol, cancer risk and, 336 Incidence, 21, 28, 147
Mortality, 29
Cigarette smoking Stage at diagnosis, 9
American Cancer Society Great American Survival rates, 11, 13, 15, 20, 36
Smokeout, 309 Treatment type statistics, 10
American Cancer Society World
Conference on Tobacco or Health, Cross-cultural studies, breast cancer, 147
“Building a Tobacco-Free World,” 241
Breast cancer and, 154 Cyclophosphamide, 267, 270
Lung cancer and, The Slowing of the Lung
Cancer Epidemic and the Need for Cytarabine, 267, 271
Continued Vigilance, 133-136 (Guest
editorial)
Cytokines, networks of, 269
Lung cancer and, smoking trends in the
United States over the past 25 years,
137-145
Stop-smoking materials available from D
American Cancer Society, 136
Circumcision, penile cancer and, relationship Dacarbazine, 267, 275
between, 306-309 (Opinion)
Dactinomycin, 267, 272
Cisplatin, 264, 267, 276
Daunorubicin, 267, 272
Cis-retinoic acid, 276
Classics in Oncology Demography, breast cancer and, 146-147
Melanomas of childhood, 40-51
Melanomas of childhood, Introduction, Depot-medroxyprogesterone acetate
37-39 (DMPA), breast cancer and, 150
Clinical trials Dexamethasone, 274
Breast cancer, biological perspective of,
contributions of the National Surgical Diet (See Nutrition)
VOL. 41,NO.6 NOVEMBER/DECEMBER 1991
Diethylstilbestrol (DES) Endometrial tissue sample, early detection, -
Breast cancer and, 152, 156 281
Summary table, 273
Epidemiology (See a/so Statistics)
Digital rectal examination, early detection, Breast cancer (female), 146-165
281 Breast cancer (male), 339-342
Lung cancer, and smoking trends in the
DNA flow cytometry, breast cancer, United States over the past 25 years,
pathologist’s role in management of, 291, 294 137-145
Melanoma of skin, 197 (Guest Editorial),
Doxorubicin, 267, 272 201
Dysplastic nevi, 209 Esophageal cancer
Incidence, 21, 28
Mortality, 27, 29
Stage at diagnosis, 8
E Survival rates, 11, 12, 15, 20, 36
Treatment type statistics, 10
Early cancer detection/prevention
Estramustine, 267, 273
American Cancer Society Guidelines for
Cancer-Related Checkup: An Update,
Estrogen receptors, breast cancer and, 156
279-282
Melanoma of the skin in 1990’s, continued
Estrogen-replacement therapy, breast
importance of early detection and role
cancer and, 150-152
of physician examination and
self-examination of skin, 201-226
Neuroblastoma, 227-230 Estrogens
Breast cancer, female, metastatic,
Editorials treatment of, 246
Breast Cancer: Change and Challenge, Breast cancer, male, 342
Summary table, 273
69-70
Cutaneous Melanoma: Opportunity for Year of acquisition of, 267
Cure, 197—199 (Guest Editorial)
Evolution of Chemotherapy, 261-263 Ethics, randomization, ethics of, 180-186
(Guest Editorial) (Opinion)
The National Cancer Data Base, 5-6
Nutrition and Cancer: Current Status, Ethinyl estradiol, 273
325-327 (Guest Editorial)
The Slowing of the Lung Cancer Epidemic Etoposide, 267 276
and the Need for Continued Vigilance,
133-136 (Guest Editorial) Eye cancer
Incidence, 28
Endocrine cancer Mortality, 29
incidence, 28 Stage at diagnosis, 9
Mortality, 29 Survival rates, 11, 14, 15
Treatment type statistics, 10
Endocrine system, breast cancer and,
149-150
aiatssscenanarseaingpdinaindnnanegeiniicatilagd
Endocrine therapy
Breast cancer, female, estrogen-
replacement therapy, 150-152 Fat intake, cancer risk and, 336
Breast cancer, female, metastatic,
treatment of, 244-247 Female cancers (See a/so entries under
Breast cancer, female, primary, specific cancers)
chemotherapy in management of, Incidence, 28, 147
231-241 Stage at diagnosis, 9
Breast cancer, male, 348-351 Survival rates, 11, 13, 15
Treatment type statistics, 10
Endometrial cancer, chemotherapeutic and
biologic agents, 266 Fiber intake, cancer risk and, 336
CA-A CANCER JOURNAL FOR CLINICIANS
Fine-needle aspiration biopsy, breast Hydroxyurea, 267, 275
cancer management, 283-284
Hypophysectomy, breast cancer, metastatic,
Fludarabine, 264, 267, 271 treatment of, 247
5—Fluorodeoxyuridine, 267, 271
5—Fluorouracil, 264, 267, 271
Food additives, cancer risk and, 336
lfosfamide, 264, 267, 270
Fresh cell therapy, unproven methods of
immuno-augmentive Therapy (IAT),
cancer management, 126-128
questionable methods of cancer
management, 357-364
Frozen-section technique, breast cancer
management, 284-285
immunohistochemical studies, breast
cancer, pathologist’s role in management of,
294-295
G
Interferon, 267
Gallbladder cancer
Interleukin-2, 267
Stage at diagnosis, 8
Survival rates, 11, 12, 15
International Union Against Cancer
Treatment type statistics, 10 (UICC), 17
Genetics
intradermal nevus, 207
Breast cancer, female, 155-156
Breast cancer, male, 4, 339
Great American Smokeout, American en
Cancer Society, 309
Junctional nevus, 205
H
Hairy cell leukemia, chemotherapeutic and K
biologic agents, 266
Keratosis, seborrheic, 207
Head and neck cancer, chemotherapeutic
and biologic agents, 266 Ketoconazole, breast cancer, metastatic,
treatment of, 247
Health counseling, early detection, 281
Kidney cancer
Heart, pericardial effusions, malignant Incidence, 28
effusions, 172-174 Mortality, 23, 29
Stage at diagnosis, 9
Hexamethylmelamine, 267, 275 Survival rates, 11, 14, 15, 36
Treatment type statistics, 10
Hodgkin’s disease
Chemotherapeutic and biologic agents,
Klinefelter’s syndrome, breast cancer
265, 266
(male), 341
Incidence, 28
Mortality, 23, 29
National Cancer Data Base analysis of, 16
Stage at diagnosis, 9 Tiinsscnsinnienieensinigheasionsiiiaiae
Survival rates, 11, 14, 35, 36
Treatment type statistics, 10
_actation, breast cancer and, 148
Hormone therapy (See Endocrine therapy)
Laetrile, unproven and questionable methods
Hydrocortisone sodium succinate, 274 of cancer management, 187-192, 317
VOL. 41,NO.6 NOVEMBER/DECEMBER 1991
Laryngeal cancer Smoking trends in the United States over
Incidence, 28 the past 25 years and, 137-145, 371
Mortality, 29 (Letter)
Stage at diagnosis, 8 Stage at diagnosis, 8
Survival rates, 11, 12, 15, 36 Survival rates, 11, 12, 15, 20, 36
Treatment, 10, 366-369 Treatment type statistics, 10
Lentigo Luteinizing hormone-releasing hormone
Simple, 205 (LHRH), breast cancer, metastatic, treatment
Solar, 207 of, 247
Letters Lymphatic system
Breast cancer, 370-371 Malignant effusions, 166-179
Laryngeal cancer, 366-369 Metastatic disease, process of metastasis,
Lung cancer and smoking, 371 301-305 (Basic Science Overview)
Mammography, 369-370
Lymphomas (non-Hodgkin’s)
Leukemia Chemotherapeutic and biologic agents,
Chemotherapeutic and biologic agents, 265, 266
265, 266 Incidence, 19, 28
Mortality, 19, 23, 29
Incidence, 19, 28, 30
Mortality, 19, 23, 26, 27, 29, 31, 32 Stage at diagnosis, 9
Stage at diagnosis, 9 Survival rates, 11, 13, 35, 36
Survival rates, 11, 14, 35, 36 Treatment type statistics, 10
Treatment type statistics, 10
Leukine, 267
M
Leuprolide, 267
Magnetic fields, breast cancer and, 154-155
Levamisole, 264, 267, 276
Male breast cancer (See Breast cancer, male)
Lifestyle factors, breast cancer and,
Malignant ascites, malignant effusions,
154-155. See also Cigarette smoking;
175-177
Nutrition
Malignant effusions, 166-179
Liver cancer Malignant ascites, 175-177
Chemotherapeutic and biologic agents, Pericardial effusions, 172-174
266 Pleural effusions, 166-172
Incidence, 21, 28
Mortality, 26, 27, 29 Mammography
Stage at diagnosis, 8
Breast cancer and, 155
Survival rates, 11, 12, 15, 20, 36 Cost, 369-370 (Letter)
Treatment type statistics, 10 Early detection and, 281
Lomustine, 267, 275 Mastectomy (See Breast cancer; Surgery:
breast cancer)
Lung, pleural effusions, malignant effusions,
166-172 Mechliorethamine, 267, 270
Lung cancer Medroxyprogesterone acetate, 274
Cardiac tamponade, 174
Chemotherapeutic and biologic agents, Megestrol acetate, 274
266
Incidence, 19, 21, 28, 30, 137, 139, Melanocytic nevi, congenital, 208-209
141-145, 147
Mortality, 19, 23, 26, 27, 29, 31, 32, Melanoma (See a/so Skin cancer)
137-141 Chemotherapeutic and biologic agents,
The Slowing of the Lung Cancer Epidemic 266
and the Need for Continued Vigilance, Cutaneous melanoma: Opportunity for
133-136 (Guest Editorial) cure, 197—199 (Guest Editorial)
CA-A CANCER JOURNAL FOR CLINICIANS
Incidence, 19, 21, 30, 201, 203, 216 N
Melanomas of childhood, 37—51 (Classic)
Mortality, 19, 31, 202, 203 National Cancer Data Base, 5-6
Opportunity for cure, 197-199 (Guest (Editorial)
Editorial) Preliminary report of, 7-18
In 1990’s, continued importance of early
detection and role of physician
National Cancer Institute, SEER program,
examination and self-examination of
lung cancer, 137
skin, 201-226
Stage at diagnosis, 8
Survival rates, 11, 13, 15, 20, 36, 201-202, National Health Federation (NHF), unproven
204 methods of cancer management, 61—64
Treatment type statistics, 10
National Surgical Adjuvant Breast and
Meiphalen, 267, 270 Bowel Project (NSABP)
Breast cancer, biological perspective of,
Menarche, age at, breast cancer and, 148 97-111
Breast cancer, metastatic, treatment of,
6-Mercaptopurine, 267, 271 242
Breast cancer, primary, chemotherapy in
Mesna, 267, 270 management of, 231
Randomization, ethics of, 184-185
Metabolic therapy, questionable cancer (Opinion)
practices in Tijuana and other Mexican border
Clinics, 310-319 Neupogen, 267
Metastatic disease Neuroblastoma
Breast cancer, 72-74 American Cancer Society screening
Breast cancer, biological perspective of, workshop, consensus statement from,
contributions of the National Surgical do children benefit from mass screening
Adjuvant Breast and Bowel Project, for neuroblastoma?, 227-230
Clinical trials, 97-111 Chemotherapeutic and biologic agents,
Breast cancer, male, 11-14, 348-351 266
Breast cancer, pathologist’s role in
Survival rates, 35, 227-228
management of, 294—295
Breast cancer, primary, chemotherapy in
management of, 231-241 Nevus
Breast cancer, staging and, 121-125 Benign, juvenile melanoma differentiated
Breast cancer, treatment of, 242-256 from, 45—46 (Classic)
Malignant effusions, 166-179 Compound, 205
Process of metastasis, 301-305 (Basic Congenital melanocytic, 208-209
Science Overview) Dysplastic, 209
Intradermal, 207
Methotrexate, 267, 271 Junctional, 205
Methyiprednisolone sodium succinate, 274 Nitrite-preserved foods, cancer risk and,
336-337
Mitomycin C, 267, 272
Nursing
Mitotane, 267, 275 American Cancer Society National
Conference on Cancer Nursing, 96
Mitoxantrone, 267 American Cancer Society Second National
Conference on Cancer Nursing
Multiple myeloma Research, 320, 338
Chemotherapeutic and biologic agents,
266 Nutrition
Incidence, estimated, 28 American Cancer Society Guidelines on
Mortality, estimated, 29 Diet, Nutrition, and Cancer, 334-338
Stage at diagnosis, 9 Breast cancer and, 152-153
Survival rates, 11, 14, 36 Cancer and, 325-327 (Guest Editorial),
Treatment type statistics, 10 328-333
VOL. 41,NO.6 NOVEMBER/DECEMBER 1991
O Penile cancer, circumcision and, relationship
between, 306-309 (Opinion)
Obesity, cancer risk and, 335
Pentostatin, 267
Oncogenes, breast cancer, pathologist role in
management of, 296 Pericardial effusions, malignant effusions,
172-174
Oophorectomy, bilateral, breast cancer,
metastatic, treatment of, 245 Pharmacology (See a/so Chemotherapy)
Breast cancer, 150-152
Opinion Breast cancer, metastatic, treatment of,
242-256
The ethics of randomization, 180-186
The relationship between circumcision and Chemotherapeutic mechanisms of action,
268
cancer of the penis, 306-309
Chemotherapy, breast cancer, primary,
Oral cancer role in management of, 231-241
Chemotherapy, evolution of, 261-263
Incidence, 19, 28, 30
Mortality, 19, 29, 31, 32 (Guest Editorial)
Stage at diagnosis, 8 Clinical trials, breast cancer, biological
Survival rates, 11, 12, 15, 36 perspective of, contributions of the
National Surgical Adjuvant Breast and
Treatment type statistics, 10
Bowel Project, 97-111
Laetrile, unproven methods of cancer
Oral contraceptives, breast cancer and,
management, 187-192
150-151
Randomization, ethics of, 180-186
(Opinion)
Orchiectomy, breast cancer, male, 349-351
Pharyngeal cancer
Osteogenic sarcoma, chemotherapeutic and
Mortality, 29
biologic agents, 265
Stage at diagnosis, 8
Ovarian cancer Survival rates, 11, 12, 15, 36
Treatment type statistics, 10
Chemotherapeutic and biologic agents,
266
Pleural effusions, malignant effusions,
Incidence, 19, 21, 28, 147 166-172
Mortality, 19, 23, 26, 29
Stage at diagnosis, 9
Plicamycin, 267, 272
Survival rates, 11, 13, 15, 20, 36
Treatment type statistics, 10
Prednisone, 267, 274
Procarbazine, 267, 276
P
Progesterone, 267
Pancreatic cancer Progestins
Chemotherapeutic and biologic agents, Breast cancer, metastatic, treatment of,
266 245-246
Incidence, 19, 28, 30 Summary table, 273
Mortality, 19, 23, 26, 27, 29, 31
Stage at diagnosis, 8 Prostate cancer
Survival rates, 11, 12, 15, 36 American Cancer Society National
Treatment type statistics, 10 Conference on, 300, 365
Chemotherapeutic and biologic agents,
Pap test, early detection, 279-281 266
Incidence, 19, 21, 28, 30
Pathology Mortality, 19, 23, 27, 29, 31, 32
Breast cancer, female, role in management Stage at diagnosis, 9
of, 283-299 Survival rates, 11, 13, 15, 20, 36
Breast cancer, male, 343-345 Treatment type statistics, 10
Pediatric oncology (See Childhood cancers) Psychological factors, breast cancer, impact
of, on sexuality, body image, and intimate
Pelvic examination, early detection, 280, 281 relationships, 112-120
CA-A CANCER JOURNAL FOR CLINICIANS
Q Sexuality, breast cancer’s impact on, and
body image and intimate relationships,
Questionable methods of cancer 112-120
management
Fresh cell therapy, 126-128 Sigmoidoscopy, early detection, 281
Immuno-augmentive Therapy (IAT),
357-364 Simple lentigo, 205
Laetrile, 187-192
National Health Federation (NHF), 61-64 Skin cancer (See also Melanoma of skin)
Questionable cancer practices in Tijuana Incidence, estimated, 28, 30
and other Mexican border clinics, Mortality, 23
310-319 Mortality, estimated, 29, 31
Smoked foods, cancer risk and, 336-337
R
Smoking
Lung cancer and, 371 (Letter)
Race differences Stop-smoking materials available from the
Lung cancer, 139 American Cancer Society, 136
Survival rates, 20, 36
Soft tissue cancer
Radiation therapy
Chemotherapeutic and biologic agents,
Breast cancer, biological perspective of, 266
contributions of the National Surgical Stage at diagnosis, 8
Adjuvant Breast and Bowel Project, Survival rates, 11, 13, 15
Clinical trials, 97-111
Treatment type statistics, 10
Breast cancer, pathologist's role in
management of, 288—290
Solar lentigo, 207
Breast cancer, primary, role in
management of, 85-96
Staging
Rapid frozen-section technique, breast Breast cancer, female, 121-125
cancer management, 284-285 Breast cancer, male, 343-345
Percentage distributions of reported cases
by site and, 8-9, 21
Rectal cancer
Incidence, 19, 21, 28, 30, 147
Mortality, 19, 23, 26, 27, 29, 31, 32 Statistics, 8-15, 19-36 (See also
Stage at diagnosis, 8 Epidemiology)
Survival rates, 11, 12, 15, 20, 36 Incidence, estimated, all sites plus major
Treatment type statistics, 10 sites, by state, 30
Incidence, estimated, by site and sex, 19
Renal pelvis, survival rates, 36 Incidence, estimated by sex, all sites, 28
Mortality, age-adjusted, world-wide, 32-33
Mortality, by sex, all sites, 29
Rhabdomyosarcoma, chemotherapeutic and Mortality, by site, age-adjusted for females,
biologic agents, 265
26 ,
Mortality, by site, age-adjusted for males,
27
S Mortality, by site and sex, 23
Mortality, estimated, all sites plus major
sites, by state, 31
Salt-cured foods, cancer risk and, 336-337 Mortality, leading causes of death, 22, 24,
25
Seborrheic keratosis, 207 Mortality, leading causes of death, for
children, 34
Selenium, cancer risk and, 337 Stage at diagnosis, by site, 21
Stage at diagnosis, summary table, 8—9
Self-examination Survival rates, by site and race, 20
Breast, early detection, 281 Survival rates, selected sites, 35
Melanoma of the skin, continued Survival rates, summary tables, 11-15
importance of early detection and role of Survival rates, trends in, by race, 36
physician examination and, 201-226 Treatment type, summary table, 10
VOL. 41,NO.6 NOVEMBER/DECEMBER 1991
Stomach cancer Thyroid cancer
Chemotherapeutic and biologic agents, 266 Incidence, 28
Incidence, 19, 21, 28 Mortality, 29
Mortality, 19, 23, 26, 27, 29, 32 Survival rates, 36
Stage at diagnosis, 8
Survival rates, 11, 12, 15, 20, 36 Thyroid gland cancer
Treatment type statistics, 10 Stage at diagnosis, 9
Survival rates, 11, 14, 15
Stool guaiac slide test, early detection, 281 Treatment type statistics, 10
Streptozotocin, 267, 275 Treatment types, summary table, statistics, 10
Surgery Tumor, Node, Metastasis (TNM) System, 7,
Breast cancer, impact of, on sexuality, 17
body image, and intimate relationships,
112-120
Breast cancer, pathologist’s role in U
management of, 285-286
Breast cancer, primary, conservative
surgery and radiation therapy (CS + RT) United States Food and Drug
in management of, 85-96 Administration (FDA), fresh cell therapy and,
Breast cancer, primary, surgical 127
management of, 71-84
Unproven methods of cancer management
Surveillance, Epidemiology and End (See Questionable methods of cancer
management)
Results (SEER) program (National Cancer
Institute), lung cancer, 137 Urinary bladder cancer
Incidence, 21, 28
Survival rates, summary tables, statistics, Mortality, 23, 27, 29
11-15. See also Statistics
Stage at diagnosis, 9
Survival rates, 11, 14, 15, 20, 36
Sweeteners, artificial, cancer risk and, 337
Treatment type statistics, 10
Urinary cancer
T
Incidence, 19
Mortality, 19, 29
Tamoxifen, 267 Uterine cancer
Breast cancer, biological perspective of, Incidence, 19, 28, 30
contributions of the National Surgical Mortality, 19, 23, 26, 29, 32
Adjuvant Breast and Bowel Project,
Clinical trials, 101
Breast cancer, metastatic, treatment of,
Vv
245
Breast cancer, primary, chemotherapy in
management of, 232-233, 236 Vinblastine, 267, 276
Taxol, 264, 267 Vincristine, 267, 276
Teniposide, 267
W
Testicular cancer
Chemotherapeutic and biologic agents,
265 Wilms’ tumor
Incidence, 21, 28 Chemotherapeutic and biologic agents, 265
Mortality, 29 Survival rates, 35
Stage at diagnosis, 9
Survival rates, 11, 13, 15, 20, 36
Treatment type statistics, 10 Z
6-Thioguanine, 267, 271
Zidovudine (AZT), randomization to, ethics
Thio-TEPA, 267, 270 of, 183—184 (Opinion)
CA-A CANCER JOURNAL FOR CLINICIANS